Podcast Library

As AI tools like ChatGPT move into clinics and prescription renewals, Dr. Seeds weighs their real limits against the hype. He argues pattern-matching software cannot interpret changing patient biology or replace mechanistic reasoning, while acknowledging AI can help synthesize histories and structure data when used as a support tool.

Alzheimer's gets reframed as a phenotype rather than a single plaque disease. The discussion breaks down five converging drivers: amyloid and tau from lost proteostasis, microglial neuroinflammation, mitochondrial energy failure, vascular dysfunction, and insulin resistance, all tracing back to oxidative stress in the neuron over decades.

The gut and brain talk constantly. Dr. Seeds walks through how barrier breakdown, low-grade immune activation, and vagus-nerve signaling connect a struggling microbiome to neurodegeneration. Short-chain fatty acids like butyrate, dietary fiber, and metabolite signaling take center stage over simplistic good-versus-bad bug thinking.

Fresh off a review paper published in JAAOS Global Research and Reviews with co-authors Dr. Omar Raman and Dr. Stephen Lee, Dr. Seeds discusses therapeutic peptides in orthopedics. The conversation covers wound-healing agents like BPC-157 and GHK-Cu, growth hormone secretagogues, and the need for rigorous clinical trials.

A single 81 mg aspirin does far more than thin blood. Dr. Seeds explains how acetylation shuts down COX-1 while retasking COX-2 to produce pro-resolving mediators like resolvins and lipoxins from omega-3s, plus its effects on the cGAS-STING pathway, PPAR alpha and the resolution of chronic inflammation, along with who should avoid it.

Red light therapy and cold plunge headline this look at popular rejuvenation tools and where the marketing outruns the science. Dr. Seeds explains how red light sparks the electron transport chain and cytochrome c oxidase to support soft-tissue healing and skin, while cautioning that its effects stay superficial and short-lived.

A back-to-basics look at cellular medicine, told by the innovator behind the framework. Dr. Seeds lays out four pillars: redox balance, mitochondrial signaling, core metabolic pathways, and cellular resilience, then traces how his orthopedic practice revealed that treating the cellular environment, not just the diagnosis, changes patient outcomes.

Sarcopenia takes center stage as Dr. Seeds dismantles the fear that GLP-1 peptides cause muscle loss. Preserving lean mass during weight loss comes down to adequate protein and leucine, resistance training, and slow, deliberate fat loss that lets the body build efficient, mitochondria-rich muscle.

Often overlooked, the lymphatic system drains cellular debris and activates immune defenses through nodes rich in T and B cells. Dr. Seeds explains why lymph flow and the brain's glymphatic drainage are redox-driven, when lymphatic massage genuinely helps, and how stage-four sleep clears amyloid and tau.

Bad breath is often a window into the oral microbiome. Dr. Seeds connects chronic halitosis to dysbiosis, biofilm and plaque, redox imbalance and immune dysregulation in the gums, tracing how these bacteria and their endotoxins contribute to heart disease, neuroinflammation and insulin resistance. Saliva, lactoferrin and flossing emerge as key defenses.

Dr. Seeds answers the podcast's namesake question and defines redox as the movement of electrons in the mitochondria that drives energy production. He walks through reactive oxygen species as signaling agents, the body's own antioxidant system governed by NFR2, and why supplementing antioxidants can disrupt the balance the cell manages on its own.

Platelet-rich plasma delivers a burst of growth factors like PDGF, VEGF, and TGF-beta, but Dr. Seeds argues its roughly fifty-fifty results hinge on the cellular environment it enters. The episode covers preparing patients metabolically, pairing PRP with stem cell signaling, and why insulin resistance is a clear contraindication.

Stem cell clinics promise regeneration, but Dr. Seeds pushes back hard on the marketing. He distinguishes embryonic, mesenchymal, and hematopoietic cells, explains what the FDA actually permits, and stresses that stem cells work through signaling and the secretome, so results depend on first repairing the patient's cellular environment.

Why longevity works better as a marketing term than a health goal. The conversation distinguishes chasing chronological years from building healthspan and biological age, questions whether expensive longevity panels are worth the money, and returns the focus to cellular function as the real target of aging well.

Guests Dr. Carl Paige and Terri return to explore how quantum biology, electron flow, coherence, and circadian rhythm shape cellular function. The conversation grounds these ideas in patient care, emphasizing trust, small early wins, and go-to peptides such as thymosin alpha-1, BPC-157, and Selank.

Dr. Carl and Terri Paige of Louisville's Medical Transformation Center join the show to share their origin story. Carl recounts how his search to resolve Terri's gut and autoimmune issues pulled him beyond conventional primary care toward cellular medicine, and the couple reflects on meeting Dr. Seeds at the early International Peptide Society.

Preparing the cell for cold-weather illness means fueling energy and immune defense, not loading up on antioxidants. Dr. Seeds explains why routinely taking vitamin C, vitamin E or NAC can leave you over-reduced and less able to fight viruses, and how zone 2 training, brief cold exposure and sauna fit a smarter seasonal strategy.

Mark Newman, founder of Precision Analytical and creator of the DUTCH test, explains how dried urine testing captures a dynamic, functional picture of hormone metabolism. He and Dr. Seeds discuss retiring the old estrogen metabolism pie chart, the need for scientific humility, and building reports clinicians can actually interpret.

Building on his book The Quantum Power of GLP-1 Peptides, Dr. Seeds shares a gentler alternative to intermittent fasting: a four-day graded calorie restriction cycle. The talk covers how catabolism, AMPK, cortisol, and thyroid interact, why constant fasting can backfire, and how cycling supports the microbiome and cellular adaptation.

Wellness thought leader Lea Llovio joins to explore how belief, mindset, and emotional interference shape healing. She and Dr. Seeds discuss why both patient and practitioner need genuine investment for protocols to work, how guilt and negative thought patterns block progress, and the practice of radical self-acceptance.

Exercise may be the brain's best medicine. Dr. Seeds details how resistance training and aerobic work raise BDNF through muscle-derived irisin, lactate fueling, and the AMPK to PGC-1 alpha pathway. The result is stronger synaptic plasticity, sharper cognition, and greater resilience against inflammation and insulin resistance.

Your cells run on 24-hour rhythms coordinated by a master clock in the hypothalamus. Dr. Seeds explains how morning light resets the system, why insulin sensitivity and AMPK peak early while mTOR favors afternoon training, and how NAD salvage and sirtuin activation set up nightly cellular repair.

A pre-print trial claiming semaglutide slows epigenetic aging in HIV patients with lipohypertrophy sparks a pointed discussion of methylation clocks. Dr. Seeds argues these aging biomarkers predict morbidity and mortality but should not replace validated mechanisms, walking through how GLP-1s act on AMPK, mTOR and brain plasticity that he says already prove their value.

Creatine gets demystified as far more than a bodybuilding staple. Dr. Seeds frames it as an on-demand ATP battery built through phosphocreatine in the mitochondria, then explores its reach into brain energy, glutamate recycling, anxiety, and methylation. The team also untangles the creatine versus creatinine confusion.